# Acrivon Therapeutics, Inc.: insider transactions

ACRV · Nasdaq · CIK 1781174 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acrv.md) · [Financials](/companies/acrv/financials.md) · [Filings](/companies/acrv/filings.md) · [Insiders](/companies/acrv/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Miller Mary](/insiders/1841088.md) | Chief Legal Officer, Officer | Sale (S) | 513 | $1.84 | $943.92 | [Form 4](/filings/0000905148-26-004554.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 16:05 ET. No prices; not investment advice.